Pages that link to "Item:Q454783"
From MaRDI portal
The following pages link to Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783):
Displaying 6 items.
- A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate (Q1733138) (← links)
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
- Number of patients per cohort and sample size considerations using dose escalation with overdose control (Q1929695) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Adjusting Simon's optimal two‐stage design for heterogeneous populations based on stratification or using historical controls (Q3299096) (← links)
- A nonparametric Bayesian method for dose finding in drug combinations cancer trials (Q6626759) (← links)